Screener
National Health Investors NHI Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.
The source filing: National Health Investors’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000135
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Distributions received from equity method investment | — | 415 |
| Net cash used in investing activities | (103,886) | (75,469) |
| Cash flows from financing activities: | ||
| Proceeds from revolving credit facility | 140,000 | 261,000 |
| Repayments of revolving credit facility | (35,000) | (145,000) |
| Repayments of term loans | — | (112) |
| Proceeds from issuance of common shares, net | — | 65,483 |
| Payments of equity issuance costs | — | (47) |
Item 1. Financial Statements
FAQ
- What is National Health Investors's debt issuance proceeds?
- National Health Investors (NHI) reported debt issuance proceeds of $140M in Q1 2026.
- How has National Health Investors's debt issuance proceeds changed year-over-year?
- National Health Investors's debt issuance proceeds decreased by 46.4% year-over-year, from $261M to $140M.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about National Health Investors's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude